Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Anxiety and Depression
NCT02035878Phase 2Unknown
- Sponsor
- Acadia University
- Start
- Aug 2012
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Acadia University. Primary endpoints: Depression Anxiety and Stress Scale at 22 weeks and Anxiety Sensitivity Index at 22 weeks. Status: unknown.
02
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02035878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035878.